NCT03542227View on ClinicalTrials.gov

Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine

CompletedOBSERVATIONAL
Enrollment

63

Participants

Timeline

Start Date

December 11, 2017

Primary Completion Date

January 11, 2022

Study Completion Date

June 23, 2022

Conditions
Human Papilloma Virus Infection
Interventions
OTHER

First-void urine collection

Collection of ca. 20 ml of first-void urine with the Colli-PeeTM device (Novosanis) during visit at the Centre for the Evaluation of Vaccination.

OTHER

Blood draw

Blood sample collection (5-10 cc) by a study nurse of Centre for the Evaluation of Vaccination.

Trial Locations (1)

2610

university of Antwerp - centre for the evaluation of vaccination, Wilrijk

All Listed Sponsors
lead

Universiteit Antwerpen

OTHER

NCT03542227 - Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine | Biotech Hunter | Biotech Hunter